Delivery Order SPE2DR25D3111-SPE2DR26FF3QR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Januvia 100 mg tablets (90-count packages) with a ceiling value of $1,056.72. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order is set to be completed by November 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $1,761.10. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count) valued at $1,122.26 under a firm fixed price contract. This delivery order, issued on August 27, 2025, with completion scheduled for August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made through competitive procurement with no set-aside designation, and the product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $2,150.79. The award, issued on December 3, 2025, with completion expected by December 4, 2025, represents a small-value pharmaceutical procurement executed through a competitive process with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (1,000 units) under a firm fixed-price contract valued at $35,054.04. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-set-aside delivery order represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government and will be performed at the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Januvia 100 mg tablets (90-count packages) with a ceiling value of $8,167.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a small-value transaction within the broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count) valued at $4,732.64, with an ultimate completion date of September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical procurement under a larger contract vehicle. The ordering activity and AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serve as the contracting entities and place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count package) valued at $1,109.94 under a firm fixed-price contract. This delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count units) with an ultimate completion date of August 18, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle with DLA. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3QRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count) with a ceiling value of $1,056.72 under a firm fixed-price contract. The order, issued on December 16, 2025, with an ultimate completion date of December 17, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. No set-aside designation was used for this competitive award, and performance will occur at the vendor's Conshohocken, Pennsylvania location. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, including specialty pharmaceuticals for military and veteran healthcare systems. The prime IDC serves as a flexible global pharmaceutical support vehicle enabling delivery of medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/15/25 |